Spyre Therapeutics Inc

0
FRA:3920 (USA)  
€ 30.65 (+3.9%) Nov 4
At Loss
P/B:
8.15
Market Cap:
€ 1.64B ($ 1.80B)
Enterprise V:
€ 1.50B ($ 1.64B)
Volume:
-
Avg Vol (2M):
-
Trade In:

Spyre Therapeutics Inc Valuation Measures